Medasense Biometrics Ltd.’s Post

This morning, at the Controversies in Dialysis Access (CiDA) 2024 meeting (3–5 October, Washington D.C., USA), Robert Shahverdyan, MD 🇦🇲🇩🇪 (Hamburg, Germany) gave a presentation sharing the one-year results of the VENOS-1 first-in-human study, which examined the Velocity (Venova Medical, Inc.) percutaneous arteriovenous fistula (pAVF). To learn more about these new results, follow the link below to read the full article!

Glucotrack is advancing diabetes care by teaming up with Cirtec Medical to bring an implantable Continuous Blood Glucose Monitor to life. Dive into how this collaboration could change the game for diabetes management. Read the full article by clicking below. #HealthTech #Innovation

The global Implantable Venous Access Port market was valued at US$ 453.8 million in 2023 and is anticipated to reach US$ 645.5 million by 2030 witnessing a CAGR of 5.1% during the forecast period 20242030. The leading products represented by BD B. Braun Medical AngioDynamics Smiths Medical and Teleflex occupy a leading position in the international market accounting for 85.5% of the global market. #GlobalImplantableVenousAccessPortMarket #MedicalDevices #HealthcareIndustry #IntravenousChemotherapy #NutritionalSupportTreatment #TitaniumInfusionPort #PlasticInfusionPort #MarketGrowth #MedicalTechnology #MinimallyInvasiveProcedures

The global market for Portable Patient Controlled Analgesia PumpPCA Pump was estimated to be worth US$ 490.2 million in 2023 and is forecast to a readjusted size of US$ 711.8 million by 2030 with a CAGR of 5.6% during the forecast period 20242030The global medical device market is estimated to be US$603.3 billion in 2023 and is expected to grow at a CAGR of 5% over the next six years. #PCAPump #PainManagement #HealthcareInnovation #MedicalDevices #PatientCare #ChronicPain #SurgeryRecovery #GlobalMarket #HealthcareTechnology #PatientSatisfaction

👏 FDA grants 510(k) clearance for Varian’s IntelliBlate microwave ablation system, designed for soft tissue ablation. The system is engineered to offer clinicians increased predictability, precision, and control during ablation procedures. It creates large, controlled spherical ablation zones, ensuring predictable treatment outcomes. Varian Interventional Solutions Vice-president and Chief Medical Officer Dr David Hahn, MD said: “IntelliBlate combines the features our customers say are most important for an efficient, integrated solution to seek improved levels of performance in microwave ablation.“ “This innovative system brings new versatility in treatment options, fueling clinician-driven innovation to tackle a wide variety of cases. Real-time monitoring and treatment information at the tissue level aim to further empower care teams with the confidence to deliver highly personalised care to patients.” Read more here: https://lnkd.in/dfSJ3mZZ 📰 Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/dU7hUz8B #Varian #Intelliblate #MedicalTechnology #Innovation #GuidedSolutions

Lower Extremity Lymphedema Treatment Revolutionized with Dayspring’s Superior Efficacy and Patient Satisfaction in TEAYS Study The TEAYS clinical study, led by Dr. Michael Barfield from The University of Tennessee Health Science Center, demonstrated that Koya Medical, Inc.’s Dayspring device outperforms advanced pneumatic compression devices in treating lower extremity lymphedema. Dayspring’s wearable, mobile design allows patients to stay active during treatment, offering greater comfort and convenience than traditional APCDs. The study showed superior clinical efficacy and patient satisfaction, positioning Dayspring as a breakthrough in lymphedema care. Koya Medical, Inc.'s success with Dayspring aligns with modern healthcare's emphasis on improving quality of life for patients with chronic conditions. For more details please click the link! https://lnkd.in/dsw3XsiK #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical 

According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #MedicalDevices #Chemiluminescence #Immunoassay #Healthcare #Diagnostics #ECLIA #CLEIA #CLIA #PatientCare #MedicalResearch

The global market for Disposable Patient Controlled Analgesia PumpPCA Pump was estimated to be worth US$ 490.2 million in 2023 and is forecast to a readjusted size of US$ 711.8 million by 2030 with a CAGR of 5.6% during the forecast period 20242030The global medical device market is estimated to be US$603.3 billion in 2023 and is expected to grow at a CAGR of 5% over the next six years. #PCAPump #PainManagement #HealthcareInnovation #MedicalDevices #PatientCare #GlobalMarket #ChronicPain #PostOperativeCare #HealthcareTechnology #PatientSatisfaction

The MDCG 2024-10 guidance on the ‘Clinical evaluation of orphan medical devices’ was released earlier this month, introducing the concept of orphan devices. Understanding this guidance is crucial for manufacturers of devices targeting rare conditions or rare cohorts of patients. We have been busy here at #MantraSystems reviewing the new guidance and understanding how this affects our Clinical Evaluations! We will be publishing an article next week summarising the essential insights from MDCG 2024-10. #medicaldeviceregulation #eumdr